Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04997499 · ClinicalTrials.gov registry record · NA

Adolescent Subcutaneous (SQ) Injection Video Validation

A NA study of Contraception and Medication Compliance, sponsored by Tufts Medical Center.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04997499 is a NA study of Contraception and Medication Compliance that is active but no longer recruiting, run by Tufts Medical Center. The registered enrollment target is 30 participants, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04997499, a NA study of Contraception and Medication Compliance, is active but no longer recruiting, sponsored by Tufts Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This is a study to determine if a video that utilizes a peer to teach self administration of subcutaneous depot medroxyprogesterone is both effective and well accepted by adolescent patients who are already receiving ongoing treatment with depot medroxyprogesterone by a medical provider via an inter muscular injection. Self administration can be done at home and therefore offers an alternative to traveling to a medical office.

Interventions

  • BEHAVIORAL watch an instructional video

Study Locations (1)

Massachusetts

  • Tufts Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-09-29
Est. Completion 2026-12
Phase NA

Sponsor

Tufts Medical Center

169 total trials

What the Registry Record Tells You About NCT04997499

The ClinicalTrials.gov registry entry for NCT04997499 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (93% lower). The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which watch an instructional video is the first listed.

NCT04997499 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04997499 about?

NCT04997499 is a clinical study titled "Adolescent Subcutaneous (SQ) Injection Video Validation". This is a study to determine if a video that utilizes a peer to teach self administration of subcutaneous depot medroxyprogesterone is both effective and well accepted by adolescent patients who are already receiving ongoing treatment with depot medroxyprogesterone by a medical provider via an inter...

What is the current status of trial NCT04997499?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-09-29. Estimated completion is 2026-12.

What conditions does trial NCT04997499 study?

This clinical trial studies the following conditions: Contraception, Medication Compliance, Self-Evaluation.

What interventions are being tested in trial NCT04997499?

The interventions under investigation include: watch an instructional video (BEHAVIORAL).

Who is sponsoring clinical trial NCT04997499?

This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04997499 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraception

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.